Sfoglia per AUTORE
SPALLANZANI A
Collezione AOU San Luigi di Orbassano
Items : 4
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial. in The Lancet. Oncology / Lancet Oncol. 2024 Dec;25(12):1539-1550. doi: 10.1016/S1470-2045(24)00580-1. Epub 2024 Nov 15.
2024
AOU San Luigi di Orbassano
Randon G; Lonardi S; Fassan M; Palermo F; Tamberi S; Giommoni E; Ceccon C; Di Donato S; Fornaro L; Brunetti O; De Vita F; Bittoni A; Chini C; Spallanzani A; Nappo F; Bethaz V; Strippoli A; Latiano T; Cardellino GG; Giuliani F; Morano F; Niger M; Raimondi A; Prisciandaro M; Pircher CC; Sciortino C; Marchesi S; Garattini SK; Airò G; et alii...
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial. in BMC cancer / BMC Cancer. 2019 Mar 29;19(1):283. doi: 10.1186/s12885-019-5498-3.
2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
Ciuffreda L; Basso M; Catalano V; Bracarda S; Verusio C; Maiello E; Cinieri S; Giuliani F; Tassinari D; Frassineti GL; Spallanzani A; Bonetti A; Tortora G; Scagliotti G; Pinotti G; Tomasello G; Bertolini A; Zaniboni A; Longarini R; Luporini AG; Rimassa L; Di Costanzo F; Cardellino GG; Scartozzi M; Berardi R; Di Donato S; Lonardi S; Tamberi S; Antista M; et alii...
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients. in European journal of endocrinology / Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570.
2019
AOU San Luigi di Orbassano
Cosentini D; Badalamenti G; Grisanti S; Basile V; Rapa I; Cerri S; Spallanzani A; Perotti P; Musso E; Laganà M; Ferrari VD; Luppi G; Dalla Volta A; Incorvaia L; Sigala S; Russo A; Volante M; Terzolo M; Berruti A;
Sunitinib in patients with pre-treated pancreatic neuroendocrine tumors: A real-world study. in Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.] / Pancreatology. 2018 Mar;18(2):198-203. doi: 10.1016/j.pan.2018.01.005. Epub 2018 Jan 12.
2018
AOU San Luigi di Orbassano
Rinzivillo M; Fazio N; Pusceddu S; Spallanzani A; Ibrahim T; Campana D; Marconcini R; Partelli S; Badalamenti G; Brizzi MP; Catena L; Schinzari G; Carnaghi C; Berardi R; Faggiano A; Antonuzzo L; Spada F; Gritti S; Femia D; Gelsomino F; Bongiovanni A; Ricci S; Brighi N; Falconi M; Delle Fave G; Panzuto F;